New Jersey investigates Amgen's Enbrel activity

01/17/2008 | NYTimes.com · Seattle Times, The

The New Jersey attorney general has asked Amgen to submit documentation on the marketing push and prescription activity for its best-selling psoriasis treatment, Enbrel, following claims of unethical marketing by two former sales representatives. Amgen said it would cooperate with the investigation and said the accusations have no merit.

View Full Article in:

NYTimes.com · Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Actuary
Meridian Health Plan
Detroit, MI
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX